dual glp 1 and gip receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Tirzepatide's Unique Mechanism of Action

Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care

Originally designed to manage type 2 diabetes (T2D), these drugs have rapidly expanded their therapeutic reach, offering significant benefits for ob

Learn what retatrutide does and how it affects appetite, blood sugar and energy use

New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.

Explore how GLP-1 agonists are reshaping industries by changing consumer preferences